Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416414 · ClinicalTrials.gov registry record
Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients
A clinical trial, sponsored by QIAGEN Gaithersburg.
- Terminated
- Registry status
- 166
- Enrollment target
NCT02416414: Clinical Trial study, sponsored by QIAGEN Gaithersburg.
NCT02416414 is a clinical trial that was terminated before completion, run by QIAGEN Gaithersburg. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02416414 was terminated before completion, sponsored by QIAGEN Gaithersburg.
- TERMINATED
- Registry status
- 166 participants
- Enrollment target
Study Summary
To compare the performance of the QuantiFERON Monitor assay against existing methodology.
Interventions
- DEVICE QuantiFERON Monitor Assay
- DEVICE Existing methodology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2015-07 |
| Est. Completion | 2016-02 |
Why NCT02416414 stopped before completion
NCT02416414 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which QuantiFERON Monitor Assay is the first listed.
NCT02416414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02416414 about?
NCT02416414 is a clinical study titled "Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients". To compare the performance of the QuantiFERON Monitor assay against existing methodology.
What is the current status of trial NCT02416414?
This trial is currently terminated. The enrollment target is 166 participants. The study started on 2015-07. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02416414?
The interventions under investigation include: QuantiFERON Monitor Assay (DEVICE), Existing methodology (DEVICE).
Who is sponsoring clinical trial NCT02416414?
This trial is sponsored by QIAGEN Gaithersburg, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia